South & Central America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type, Treatment Type, Infection Severity, and End User

Description

List of Tables

The South & Central America diabetic foot ulcer market was valued at US$ 356.91 million in 2022 and is expected to reach US$ 549.39 million by 2030; it is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Use of 3D Printing in Wound Care Management Fuels the South & Central America Diabetic Foot Ulcer Market

Skin tissue damage caused by various indications due to diabetes and vascular diseases significantly burdens the healthcare systems. 3D bioprinting is based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still nascent, 3D printing can potentially revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that promote angiogenesis for dermal regeneration. In addition, 3D bioprinting helps patch large wounds that are hard to heal with standard techniques. The use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer market in the coming years.

South & Central America Diabetic Foot Ulcer Market Overview

The South & Central America diabetic foot ulcer market is estimated to grow at a CAGR of 5.5% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth.

According to IDF Diabetes Atlas, in 2021, diabetes accounted for US$ 65 billion in expenditure in South & Central America, which is estimated to reach US$ 80 billion by 2030. Thus, the increasing healthcare spending and the rising prevalence of diabetes in the region are factors expected to boost market growth, ultimately increasing wound care product use. Additionally, several market players are implementing awareness and training courses to empower clinicians to enhance clinical knowledge and understand treatment options for chronic wounds such as diabetic foot ulcers. In April 2021, Medline launched a new series of chronic wound care courses in Argentina to train clinicians with advanced treatment options for diabetic foot ulcers. Such initiatives will support the market growth in Argentina.

South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the South & Central America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the South & Central America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the South & Central America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the South & Central America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the South & Central America diabetic foot ulcer market is segmented into Brazil, Argentina, the Rest of South & Central America. Brazil dominated the South & Central America diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the South & Central America diabetic foot ulcer market.

Product Code: BMIRE00029574

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Diabetic Foot Ulcer Market Landscape

4.1 Overview

5. South & Central America Diabetic Foot Ulcer Market - Key Industry Dynamics

5.1 Market Drivers:
- 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
- 5.1.2 Surge in Geriatric Population
5.2 Market Restraints
- 5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
- 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
- 5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market - South & Central America Market Analysis

6.1 South & Central America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
- 7.3.1 Overview
- 7.3.2 Advanced Wound Care Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Alginate Dressings
  - 7.3.3.1 Overview
  - 7.3.3.2 Alginate Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Hydrofiber Dressings
  - 7.3.4.1 Overview
  - 7.3.4.2 Hydrofiber Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Foam Dressings
  - 7.3.5.1 Overview
  - 7.3.5.2 Foam Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Collagen Dressing
  - 7.3.6.1 Overview
  - 7.3.6.2 Collagen Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Film Dressing
  - 7.3.7.1 Overview
  - 7.3.7.2 Film Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Other Dressings
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
- 7.4.1 Overview
- 7.4.2 Biologics: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Growth Factors
  - 7.4.3.1 Overview
  - 7.4.3.2 Growth Factors: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Skin Graft
  - 7.4.4.1 Overview
  - 7.4.4.2 Skin Graft: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
- 7.5.1 Overview
- 7.5.2 Therapy Device: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.3 Negative Pressure Wound Therapy
  - 7.5.3.1 Overview
  - 7.5.3.2 Negative Pressure Wound Therapy: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.4 Ultrasound Therapy
  - 7.5.4.1 Overview
  - 7.5.4.2 Ultrasound Therapy: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

8.1 Overview
8.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
- 8.3.1 Overview
- 8.3.2 Neuropathic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
- 8.4.1 Overview
- 8.4.2 Ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
- 8.5.1 Overview
- 8.5.2 Neuro-ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

9.1 Overview
9.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
- 9.3.1 Overview
- 9.3.2 Mild: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Moderate: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.4 Severe: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

10.1 Overview
10.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
- 10.5.1 Overview
- 10.5.2 Home Care: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - South & Central America Market Analysis

11.1 South & Central America Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 South & Central America Diabetic Foot Ulcer Market by Country
  - 11.1.1.2 Brazil
    - 11.1.1.2.1 Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.2 Brazil Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.2.3 Brazil Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.2.3.1 Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.2.3.2 Brazil: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.2.3.3 Brazil: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.2.4 Brazil Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.2.5 Brazil Diabetic Foot Ulcer Market, by End User
  - 11.1.1.3 Argentina
    - 11.1.1.3.1 Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.2 Argentina Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.3.3 Argentina Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.3.3.1 Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.3.3.2 Argentina: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.3.3.3 Argentina: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.3.4 Argentina Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.3.5 Argentina Diabetic Foot Ulcer Market, by End User
  - 11.1.1.4 Rest of South & Central America
    - 11.1.1.4.1 Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.4.2 Rest of South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.4.3 Rest of South & Central America Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.4.3.1 Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.4.3.2 Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.4.3.3 Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.4.4 Rest of South & Central America Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.4.5 Rest of South & Central America Diabetic Foot Ulcer Market, by End User

12. Diabetic Foot Ulcer Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Diabetic Foot Ulcer Market - Key Company Profiles

13.1 Convatec Group Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 3M Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Coloplast AS
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Smith & Nephew Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 B. Braun SE
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Molnlycke Health Care AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MiMedx Group Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medline Industries LP
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Organogenesis Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms